ESCRS 2023: Krysten Williams talks about bringing Heidelberg image quality into the surgical theater

News
Video

At the 2023 European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Krysten Williams, head of marketing and education at Heidelberg Engineering, spoke to our team about the newest imaging advancements in the clinic and the operating room.

Ophthalmology Times Europe is covering this year's European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Austria. We caught up with Krysten Williams, head of marketing and education at Heidelberg Engineering, who spoke to our team about the newest imaging advancements in the clinic and the operating room.

Transcript

Editor's note: This transcript has been edited for clarity.

Krysten Williams: Hi, my name is Krysten Williams and I'm head of marketing and education at Heidelberg Engineering. So our theme for the ESCRS this year is "Heidelberg Engineering Image Quality." And it's really important because we started in the posterior segment, and we're known for our retinal images. But in recent years, we've moved into the anterior segment space. And this year, what we're showing is that we're bringing Heidelberg image quality into the surgical theater.

We are collaborating with Bausch + Lomb along with the SeeLuma™ microscope. And here at the ESCRS, we're very excited to show the integrated OCT into the SeeLuma™ platform. The fact that we're moving into the surgical space is surprising because for many years, we've been known as a diagnostic image – imaging company.

Now for the first time, we're bringing OCT images and the power of the diagnostic capability into the surgical space and doctors can actually have this information at their fingertips right in the surgical theater, because we are we've gone from posterior to anterior, and from the diagnostic clinic into the surgical theater. We have a complete ecosystem that integrates our products and gives us that complete continuum between clinic and the OR.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.